India’s Pharma Industry: A Growing Global Powerhouse

India’s pharma industry is expanding rapidly, projected to reach US$ 65 billion by 2024 and US$ 130 billion by 2030. With over US$ 25 billion from exports, India supplies 20% of global generic drugs, solidifying its role in the global healthcare sector.

• Leading Companies: Lupin Pharmaceuticals, Cipla, and Sun Pharmaceuticals are driving innovation.
• Hospital Market Growth: Valued at US$ 98.98 billion in FY23, expected to reach US$ 193.59 billion by FY32.
• Global Impact: Pharma sector companies in India are reshaping healthcare worldwide.

The top pharma companies in India are setting new global benchmarks. Learn more at the India Brand Equity Foundation